Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
CNS Pharmaceuticals, Inc. (CNSP) had Debt to Equity Ratio of 0.07 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-15.85M |
|
-- |
|
-- |
|
$15.99M |
|
$-15.99M |
|
$0.14M |
|
$-15.85M |
|
$-15.85M |
|
$-15.85M |
|
$-15.85M |
|
$-15.85M |
|
$-15.85M |
|
$-15.99M |
|
$-15.98M |
|
0.44M |
|
0.44M |
|
$-35.75 |
|
$-35.75 |
|
| Balance Sheet Financials | |
$8.10M |
|
$0.02M |
|
$0.52M |
|
$8.62M |
|
$4.10M |
|
-- |
|
-- |
|
$4.10M |
|
$4.52M |
|
$4.52M |
|
$4.52M |
|
0.63M |
|
| Cash Flow Statement Financials | |
$-13.81M |
|
$-0.02M |
|
$14.57M |
|
$6.46M |
|
$7.20M |
|
$0.74M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.98 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.07 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-350.48% |
|
-350.48% |
|
-183.81% |
|
-350.48% |
|
$7.14 |
|
$-31.22 |
|
$-31.18 |
|